The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.
about
Concentrative transport of antifolates mediated by the proton-coupled folate transporter (PCFT, SLC46A1); augmentation by a HEPES buffer.Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis.
P2860
The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The promise and challenges of ...... erapeutic targeting of cancer.
@en
The promise and challenges of ...... erapeutic targeting of cancer.
@nl
type
label
The promise and challenges of ...... erapeutic targeting of cancer.
@en
The promise and challenges of ...... erapeutic targeting of cancer.
@nl
prefLabel
The promise and challenges of ...... erapeutic targeting of cancer.
@en
The promise and challenges of ...... erapeutic targeting of cancer.
@nl
P2093
P2860
P1476
The promise and challenges of ...... erapeutic targeting of cancer.
@en
P2093
Aleem Gangjee
Larry H Matherly
Zhanjun Hou
P2860
P2888
P356
10.1007/S00280-017-3473-8
P577
2017-11-10T00:00:00Z